Our mission - is to facilitate the transition of the Russian pharmaceutical market to develop into mature, be a guide on the course of development of the potential of all the pharmaceutical market participants, thereby improving the quality of life for the end user and society in general. Despite the relatively high susceptibility to Russia's external economic and financial risks, imbalances in the domestic policy and great social disparities, the pharmaceutical market in Russia has had a stable positive growth for the last few years.
By the order of the Minister of Health of the Republic of Kazakhstan dated January 31, 2018, No. 39, the rules for the formation of lists of procurement of medicines and medical products within the guaranteed volume of free medical care and in the system of compulsory social health insurance were approved, according to the online database.zakon.kz.
The created effective legal environment settled the institution of intellectual property and today allows pharmaceutical companies not only to plan their activities for a long-term perspective, but also to be confident in protecting their rights.
Monitoring is the activity of monitoring, conducting, collecting data and presenting results in accordance with the Protocol, the Standard Operating Procedures, Good Clinical Practice and Regulatory Requirements. The person appointed by the clinical trial organizer and is responsible for monitoring it, is called the Clinical Research Associate (CRA) Clinical Research Monitor or Clinical Research Associate (CRA).
The first applications for the registration of medicines are filed according to the unanimous rules of the Eurasian Economic Union (EAEC). Representatives of the Kazakhstan regulatory body at the Pharmaceutical Forum of the countries of the Eurasian Economic Community and the CIS reported this. The Belarusian regulators have confirmed their willingness to accept such applications.
According to the DSM Group, in 2017, 340.7 million packages of dietary supplements worth 51.2 billion rubles in retail prices were sold through the pharmacy network. In the 12 months of 2017, the BAA market grew by 4.6% in rubles and by 1.7% in packs compared to 2016.
Ministry of Health of Russia has developed amendments to the Code of the Russian Federation on administrative offenses. This draft of the federal law introduces two changes in the Administrative Code of Administrative Offenses:
The success of research activities is the result of a global long-term strategy that requires attracting significant investments and qualified specialists of various fields in the discovery of new technologies.
The chances of successful completion of the work on creating a new drug are discouragingly small. The process of developing and marketing a new product on average continues for 12 years.
In the journal PNAS published an article with the results of a study conducted by a group of scientists from Washington, indicating a sharp increase in the consumption of antibacterial drugs on a global scale. The authors analyzed the factors of antibiotic consumption in the period from 2000 to 2015 in 76 countries and compiled a global consumption forecast until 2030.